- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/52 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
Patent holdings for IPC class C07C 237/52
Total number of patents in this class: 47
10-year publication summary
|
8
|
6
|
6
|
1
|
3
|
7
|
5
|
1
|
7
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hangzhou DAC Biotech Co., Ltd | 113 |
4 |
| Saudi Arabian Oil Company | 14369 |
4 |
| Biogen MA Inc. | 943 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4810 |
3 |
| Corteva Agriscience LLC | 2649 |
3 |
| Eli Lilly and Company | 4118 |
2 |
| Texas Tech University System | 661 |
2 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 175 |
2 |
| Hoffmann-La Roche Inc. | 3841 |
1 |
| The Regents of the University of California | 20902 |
1 |
| AstraZeneca AB | 2823 |
1 |
| The Goodyear Tire & Rubber Company | 2377 |
1 |
| Mitsui Chemicals Agro, Inc. | 79 |
1 |
| Boigen MA Inc. | 1 |
1 |
| Bracco Imaging S.p.A. | 317 |
1 |
| The Brigham and Women's Hospital, Inc. | 2297 |
1 |
| Drexel University | 998 |
1 |
| FMC Corporation | 815 |
1 |
| Heptares Therapeutics Limited | 73 |
1 |
| Mitsubishi Tanabe Pharma Corporation | 394 |
1 |
| Other owners | 12 |